Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-12-12
1998-10-06
Harrison, Robert H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 56, 514822, A61K 31715, A61K 31725
Patent
active
058176454
ABSTRACT:
The prevention and therapy of pulmonary embolism with pharmaceutical compositions containing low molecular weight dermatan sulfate is described. These pharmaceutical compositions are administered by subcutaneous, intramuscular or intravenous route at a daily dosage between 200 and 3000 mgs of active principle. The low molecular weight dermatan sulfate preferred in carrying out the invention has an average molecular weight equal to 5500.+-.1100 Daltons and is obtained by depolymerization of the dermatan sulfate of natural origin in the presence of hydrogen peroxide and cupric ions.
REFERENCES:
patent: 4973580 (1990-11-01), Mascellani et al.
patent: 5164378 (1992-11-01), Conti et al.
patent: 5252339 (1993-10-01), Cristofori et al.
patent: 5576304 (1996-11-01), Kakkar et al.
patent: 5763427 (1998-06-01), Weitz et al.
Bergqvist et al. Glycosaminoglycans in Prophylaxis Against Venous Thromboembolism. Advances in Experimental Medicine & Biology. vol. 313, pp. 259-274. (1992).
Cohen et al. A Dose Ranging Study of Evaluate Dermatan Sulphate in Preventing Deep Vein Thrombosis Following Total Hip Arthroplasty. Thrombosis and Haemostasis. 72(6), pp. 793-798.(1994).
Charbonnier et al. Anticoagulant Therapy in Pulmonary Embolism. Archives des Maladies du Coeur et des Vaisseaux. vol. 88, No. 11(supplemental), pp. 1755-1761. (Nov. 1995).
Gent et al. Low-Molecular Wt. Heparinoid Orgaran is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture. Circulation. 93(1), pp. 80-84. (Jan. 1996).
Baldazzi Claudia
Barbanti Maria
Zamboni Villiam
Alfa Wassermann S.p.A.
Harrison Robert H.
LandOfFree
Pharmaceutical compositions containing low molecular weight derm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing low molecular weight derm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing low molecular weight derm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-77209